Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
This number likely underrepresents actual complications given that many adverse events go unreported
The medication is currently being studied in the TRIUMPH Phase 3 clinical trial program, which is typically the final stage of testing before companies apply for FDA approval
Adverse Reactions Adverse Reactions Gastrointestinal adverse events were the most frequently observed in clinical studies of Retatrutide
American Osteopathic College of Occupational and Preventive Medicine
US$ 27.76
US$ 23.30
US$ 25.72
US$ 25.44
